News

Exelon Corporation’s EXC third-quarter 2025 earnings of 86 cents per share surpassed the Zacks Consensus Estimate of 76 cents by 13.2%. The bottom line improved 21.1% from the year-ago level of 71

Norwegian Cruise Line Holdings Ltd. NCLH reported third-quarter 2025 results, with earnings beating the Zacks Consensus Estimate, but revenues missing the same. Following the results, the company’s

Marriott International, Inc. MAR reported third-quarter 2025 results, with adjusted earnings and revenues beating the Zacks Consensus Estimate. Its earnings beat the estimate for the fourth straight

Take-Two Interactive Software TTWO is scheduled to release second-quarter fiscal 2026 results on Nov. 6.For the second quarter of fiscal 2026, Take-Two expects GAAP net revenues between $1.65

Innodata Inc. INOD is slated to release third-quarter 2025 results on Nov. 6, after the closing bell.In the last reported quarter, the company’s earnings beat the Zacks Consensus Estimate by 81.8%

Expedia Group EXPE is scheduled to report third-quarter 2025 results on Nov. 6.The Zacks Consensus Estimate for EXPE’s third-quarter 2025 revenues is pegged at $4.3 billion, indicating a 5.9%

The third-quarter 2025 earnings season is underway, and several Oil/Energy companies have already shared their results. While analysts caution that falling oil prices could make this quarter

After reporting another quarter of profit growth, Sprouts Farmers Market, Inc. SFM now faces an uncertain stretch ahead. The company’s latest quarterly results, while reflecting strong operational

Willdan Group WLDN is set to report its third-quarter 2025 earnings on Nov. 6, 2025, after the bell.

The Zacks Consensus Estimate for WLDN’s earnings for the soon-to-be-reported quarter is pegged at

Westlake Corporation WLK reported a loss of $782 million or $6.06 per share for the third quarter of 2025. This compares to a profit of $108 million or 83 cents per share in the year-ago quarter.

QuantumScape Corp.’s QS business model is starting to show results. The company has a capital-light approach focused on licensing and development work rather than large-scale manufacturing. In Q3

Vertex Pharmaceuticals VRTX reported adjusted earnings of $4.80 per share for the third quarter of 2025, surpassing the Zacks Consensus Estimate of $4.55. Earnings rose around 10% year over year.

U.S. legacy automaker Ford’s F commercial arm, Ford Pro, is becoming the company’s biggest growth engine. The segment continues to deliver strong results, with third-quarter 2025 EBIT rising 9.4%

Tuesday, November 4, 2025Pre-market futures are sinking on valuation concerns this morning. This is not from any particular event that happened this morning, though it may have something to do with

Eastman Chemical Company EMN logged third-quarter 2025 earnings of 40 cents per share, a roughly 74% decline from the year-ago quarter's figure of $1.53.

EMN posted adjusted earnings of $1.14 per

Halozyme Therapeutics HALO reported third-quarter 2025 adjusted earnings of $1.72 per share, which beat the Zacks Consensus Estimate of $1.63. Earnings rose 35.4% year over year.

Total revenues in

For the quarter ended September 2025, Premier, Inc. (PINC) reported revenue of $240 million, down 3.3% over the same period last year. EPS came in at $0.30, compared to $0.34 in the year-ago

For the quarter ended September 2025, Expeditors International (EXPD) reported revenue of $2.89 billion, down 3.5% over the same period last year. EPS came in at $1.64, compared to $1.63 in the

Palantir Technologies Inc. (PLTR) reported $1.18 billion in revenue for the quarter ended September 2025, representing a year-over-year increase of 62.8%. EPS of $0.21 for the same period compares

Financial services technology solutions provider Fidelity National Information Services, Inc. FIS is set to report third-quarter 2025 results on Nov. 5, 2025, before the opening bell. The Zacks

Axsome Therapeutics AXSM incurred a loss of 94 cents per share in the third quarter of 2025, wider than the Zacks Consensus Estimate of a loss of 82 cents. The company had incurred a loss of $1.34

TG Therapeutics TGTX reported earnings of $2.43 per share for the third quarter of 2025, which significantly beat the Zacks Consensus Estimate of 24 cents. The company had reported earnings of 2

The electronics stocks market's quarterly releases are expected to reflect the continued expansion of artificial intelligence infrastructure and data centre buildouts globally. Accelerated

Tango Therapeutics, Inc. (TNGX) came out with quarterly earnings of $0.13 per share, beating the Zacks Consensus Estimate of $0.01 per share. This compares to a loss of $0.27 per share a year ago